BB Biotech as of March 31, 2012
Portfolio Holdings for BB Biotech
BB Biotech holds 20 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 19.9 | $202M | 2.6M | 77.52 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 11.4 | $116M | 2.8M | 41.01 | |
| Gilead Sciences (GILD) | 10.2 | $103M | 2.1M | 48.86 | |
| Incyte Corporation (INCY) | 9.5 | $96M | 5.0M | 19.30 | |
| ISIS Pharmaceuticals | 6.3 | $63M | 7.2M | 8.77 | |
| Halozyme Therapeutics (HALO) | 6.0 | $61M | 4.8M | 12.76 | |
| Amylin Pharmaceuticals | 5.7 | $58M | 2.3M | 24.96 | |
| ImmunoGen | 5.2 | $53M | 3.7M | 14.39 | |
| Ariad Pharmaceuticals | 4.9 | $50M | 3.1M | 15.98 | |
| Alexion Pharmaceuticals | 4.1 | $42M | 450k | 92.86 | |
| BioMarin Pharmaceutical (BMRN) | 3.3 | $33M | 976k | 34.25 | |
| Medicines Company | 2.8 | $29M | 1.4M | 20.07 | |
| Optimer Pharmaceuticals | 2.0 | $20M | 1.4M | 13.90 | |
| Human Genome Sciences | 1.6 | $17M | 2.0M | 8.24 | |
| Theravance | 1.6 | $16M | 843k | 19.50 | |
| Dendreon Corporation | 1.6 | $16M | 1.5M | 10.66 | |
| Achillion Pharmaceuticals | 1.5 | $15M | 1.6M | 9.58 | |
| Idenix Pharmaceuticals | 1.4 | $14M | 1.4M | 9.79 | |
| Onyx Pharmaceuticals | 0.6 | $6.2M | 165k | 37.68 | |
| Endocyte | 0.5 | $4.6M | 927k | 4.98 |
